Clover Health Investments Dirección
Dirección controles de criterios 3/4
El CEO de Clover Health Investments es Andrew Toy , nombrado en Jan 2023, tiene una permanencia de 1.83 años. compensación anual total es $10.15M, compuesta por 6.9% salario y 93.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.61% de las acciones de la empresa, por valor de $10.69M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 3.7 años, respectivamente.
Información clave
Andrew Toy
Chief Executive Officer (CEO)
US$10.2m
Compensación total
Porcentaje del salario del CEO | 6.9% |
Permanencia del CEO | 1.8yrs |
Participación del CEO | 0.6% |
Permanencia media de la dirección | 2.3yrs |
Promedio de permanencia en la Junta Directiva | 3.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Clover Health: Buy The Dip, Reap The Rewards
Nov 18Clover Health Investments, Corp. (NASDAQ:CLOV) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
Nov 08Clover Health's Rally: The Payoff Of A Profitable Pivot
Nov 06There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump
Oct 03Clover Health: Changing Business Model, Seeking Profitability
Oct 03Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success
Aug 15Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Aug 14Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Aug 06Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Jun 12Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$96m |
Jun 30 2024 | n/a | n/a | -US$121m |
Mar 31 2024 | n/a | n/a | -US$157m |
Dec 31 2023 | US$10m | US$700k | -US$213m |
Sep 30 2023 | n/a | n/a | -US$226m |
Jun 30 2023 | n/a | n/a | -US$268m |
Mar 31 2023 | n/a | n/a | -US$344m |
Dec 31 2022 | US$10m | US$500k | -US$340m |
Sep 30 2022 | n/a | n/a | -US$443m |
Jun 30 2022 | n/a | n/a | -US$402m |
Mar 31 2022 | n/a | n/a | -US$615m |
Dec 31 2021 | US$142m | US$450k | -US$588m |
Sep 30 2021 | n/a | n/a | -US$527m |
Jun 30 2021 | n/a | n/a | -US$487m |
Mar 31 2021 | n/a | n/a | -US$160m |
Dec 31 2020 | US$9m | US$415k | -US$136m |
Sep 30 2020 | n/a | n/a | -US$89m |
Jun 30 2020 | n/a | n/a | -US$145m |
Mar 31 2020 | n/a | n/a | -US$272m |
Dec 31 2019 | US$424k | US$400k | -US$364m |
Compensación vs. Mercado: La compensación total de Andrew($USD10.15M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD5.54M).
Compensación vs. Ingresos: La compensación de Andrew ha sido consistente con los resultados de la empresa en el último año.
CEO
Andrew Toy (45 yo)
1.8yrs
Permanencia
US$10,154,701
Compensación
Mr. Andrew Toy Co-founded Clover Health Investments, Corp. and serves as its Director since November 2018 and served as its President since March 2019. He serves as Chief Executive Officer at Clover Health...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Co-Founder & Executive Chairman | 10.3yrs | sin datos | 18.01% $ 314.9m | |
Co-Founder | 1.8yrs | US$10.15m | 0.61% $ 10.7m | |
General Counsel | 1.1yrs | US$1.47m | 0.28% $ 4.9m | |
Chief Executive Officer of Home Care | 2.3yrs | US$1.35m | 0.16% $ 2.8m | |
Chief Executive Officer of Medicare Advantage | 1.8yrs | US$2.49m | 0.26% $ 4.5m | |
Chief Financial Officer | less than a year | sin datos | sin datos | |
Chief Technology Officer | 2.8yrs | sin datos | 0.69% $ 12.1m | |
Head of Investor Relations & Corporate strategy | no data | sin datos | sin datos | |
Chief Compliance Officer | no data | sin datos | sin datos | |
Chief People Officer | no data | sin datos | sin datos | |
Chief Medical Officer of Clover Assistant | 3yrs | sin datos | sin datos | |
Chief Medical Officer | 3.8yrs | sin datos | sin datos |
2.3yrs
Permanencia media
46yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CLOV se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Co-Founder & Executive Chairman | 10.3yrs | sin datos | 18.01% $ 314.9m | |
Co-Founder | 6yrs | US$10.15m | 0.61% $ 10.7m | |
Independent Director | 3.8yrs | US$280.93k | 0.066% $ 1.2m | |
Director | less than a year | sin datos | sin datos | |
Independent Director | 7.8yrs | US$246.55k | 0.067% $ 1.2m | |
Board Observer | no data | sin datos | sin datos | |
Independent Director | 3.7yrs | US$268.43k | 0.050% $ 877.6k | |
Independent Director | 2.3yrs | US$250.30k | 0.041% $ 719.1k | |
Independent Director | 2yrs | US$247.80k | 0.077% $ 1.3m | |
Lead Independent Director | 3.6yrs | US$320.16k | 0.044% $ 776.8k |
3.7yrs
Permanencia media
50.5yo
Promedio de edad
Junta con experiencia: La junta directiva de CLOV se considera experimentada (3.7 años de antigüedad promedio).